NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Can B Corp
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026
- Market cap
- $981.54K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$0.0050 (−25.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Can B Corp saw revenue fall 57.7% to $1.03M over the twelve months to Sep 30, 2024. Free cash flow was -$1.32M.
Revenue
$1.03M
-57.7% vs. a year earlier
Operating income
-$10.71M
TTM Q3 2024
Free cash flow
-$1.32M
FY2023
EPS, diluted
-$0.77
FY2023
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024
Valuation
- Market cap
- $981.54K
- P/E ratio
- –
- Price to sales
- 0.95
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -134.43%
Fundamentals
- Revenue
- $1.03M
- Net income
- -$13.26M
- EPS, diluted
- -$0.77
- Free cash flow
- -$1.32M
- Book value per share
- -$0.15
- Diluted shares
- 65M
Ten years at a glance
Fiscal years 2014 to 2023 and trailing twelve months, USD
Revenue
$1.03M-57.7% YoY
Gross profit
-$343.30K
Operating income
-$10.71M
Net income
-$13.26M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months